Skip to main content
Erschienen in: Diabetes Therapy 2/2018

Open Access 22.03.2018 | Author Correction

Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

verfasst von: Jelica Bjekić-Macut, Teodora Beljić Živković, Radivoj Kocić

Erschienen in: Diabetes Therapy | Ausgabe 2/2018

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1007/​s13300-018-0378-4.

Author Correction to: Diabetes Ther https://​doi.​org/​10.​1007/​s13300-018-0378-4

In the original publication, values of the doses of insulin glargine, the most commonly used basal insulin analogue under the ‘Discussion’ section was incorrectly published.
The sentence “…was similar (3100.314 ± 110.1298 U/kg body weight/day at baseline) to that in the Swedish study (0.33 ± 0.16 U/kg body weight/day)”.
Should actually say “…was similar (0.31 ± 0.12 U/kg body weight/day at baseline) to that in the Swedish study (0.33 ± 0.16 U/kg body weight/day)”.

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
verfasst von
Jelica Bjekić-Macut
Teodora Beljić Živković
Radivoj Kocić
Publikationsdatum
22.03.2018
Verlag
Springer Healthcare
Erschienen in
Diabetes Therapy / Ausgabe 2/2018
Print ISSN: 1869-6953
Elektronische ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-018-0406-4

Weitere Artikel der Ausgabe 2/2018

Diabetes Therapy 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.